Xianmin Zeng/Buck Inst.
Nerve cells derived from human stem cells, in work supported by the California Institute for Regenerative Medicine.
When California voters approved US$3billion in funding for stem-cell research in 2004, biologists flocked to the state, and citizens dreamed of cures for Parkinsons disease and spinal-cord injuries. Now, the pot of money one of the biggest state investments in science is running dry before treatments have emerged, raising questions about whether Californians will pour billions more into stem-cell research.
If they dont, that could leave hundreds of scientists without support, and strand potentially promising therapies before they reach the market. Its an issue of great concern, says Jonathan Thomas, chair of the board for the California Institute for Regenerative Medicine (CIRM) in Oakland.
CIRM is now doling out its final $650million, and its leaders are seeking money from the private sector to carry projects beyond 2020, when the money will run out. Advocates are also surveying voters to determine whether a new request for funding stands a chance in state elections next year. But critics argue against this way of funding research.
California voters saw major opportunities for stem cells in 2004 when they passed Proposition 71, which included an agreement to create the corporation that became CIRM. The move was a reaction to then-US president George W. Bushs decision in 2001 to restrict federal funds for work on human embryonic stem cells.
Since CIRM rolled out its first grants in 2006, it has funded more than 750 projects and reported alluring results from clinical trials. In March, a trial partially funded by CIRM showed that nine out of ten children born with severe combined immunodeficiency or bubble-boy disease a potentially lethal condition in which a persons immune system does not function properly, were doing well up to eight years after treatment (K.L.Shaw etal. J. Clin. Invest. http://doi.org/b6bp; 2017). They no longer need injections to be able to go to school, play outside or survive colds and other inevitable infections.
A dozen facilities constructed by CIRM have helped to push California to the forefront of research on ageing and regenerative medicine. Many grant recipients were early-career academics who had not been able to enter the stem-cell field previously because of the federal restrictions which were loosened in 2009 and the high cost of getting started in this kind of work. That barrier makes it difficult for researchers to gather the preliminary data typically required to win grants from the US National Institutes of Health (NIH).
To milk its remaining $650 million, CIRM partnered last year with the contract-research organization QuintilesIMS in Durham, North Carolina, to carry out clinical trials. CIRM leaders hope that this move will help to guide 40 novel therapies into trials by 2020.
Bob Klein, the property developer who put Proposition 71 on the ballot and established CIRM, isnt waiting for the money to run out. He leads an advocacy group, Americans for Cures, which will soon poll voters to see whether they would approve another $5 billion in funding. If it looks like at least 70% of Californians support that plan, hell start a campaign to put another initiative on the ballot in 2018.
Klein hopes that Californians will rise in support of science at a time when the Trump administration has proposed drastic cuts to the NIH budget. If public enthusiasm is not so strong, Klein says, hell aim for the 2020 elections, when voter turnout should be higher because it will coincide with the next presidential race.
Currently, CIRMs leaders are seeking other sources of support. The majority of our projects will not be ripe for interest from big pharma and the venture-capitalist community by the time we run out of funds, Thomas says. He has been courting large philanthropic foundations and wealthy individuals to raise money to continue the work.
John Simpson, who directs stem-cell oversight work at the advocacy group Consumer Watchdog in Washington DC, plans to oppose any effort to extend CIRM. I acknowledge their scientific advances, but we should not let a flawed process go further, he says. Simpson dislikes the model of using a vote to secure research funding through public bonds, because then the state lacks budgetary control.
Oversight of CIRM has been a problem in the past. In 2012, the US Institute of Medicine found that some scientists vetting grant proposals for CIRM had conflicts of interest. In response, CIRM altered its procedures but the public still felt betrayed. Jim Lott, a member of the state board that oversees CIRMs finances, says that he is not satisfied with the changes. He also argues that CIRM may not have been strategic enough in directing research. Some people say if they had a better focus, they might have achieved cures.
But researchers argue that expectations for cures after only a decade are unrealistic, given the typical pace of drug development. It would be a catastrophe for California if people say CIRM did not do what it was expected to do, says Eric Verdin, president of the Buck Institute for Research on Aging in Novato, California. Theyve built the foundation for the field and attracted people from around the world you cant just now pull the plug.
- New Progress in Stem-Cell-Free Regenerative Medicine - May 26th, 2019
- The Stem Cell Theory of Cancer | Ludwig Center | Stanford ... - May 26th, 2019
- 10 talks on the future of stem cell medicine | TED Blog - March 23rd, 2019
- Ansary Stem Cell Institute | Department of Medicine - March 10th, 2019
- PRP vs. Stem Cell Therapy in Medicine | NSI Stem Cell - March 9th, 2019
- Top Stem Cell Conferences | Stem Cell Research 2019 ... - March 8th, 2019
- Bone Marrow & Stem Cell Transplant | Weill Cornell Medicine - March 7th, 2019
- Stem Cell | Regenerative medicine | 2019 | Conference ... - January 29th, 2019
- Original Medicine Wellness Center - Functional Medicine ... - January 28th, 2019
- Stem Cell Medicine Licenses Exosome Technology for ... - January 11th, 2019
- Stem Cell Medicine | Murdoch Children's Research Institute - November 30th, 2018
- FAQs - Ocean Springs, MS - Gulf Coast Stem Cell ... - November 14th, 2018
- Hematopoietic stem cell - Wikipedia - November 14th, 2018
- Stem Cell Conferences | Regenerative Medicine Conferences ... - November 12th, 2018
- Stem Cell Conferences | Regenerative Medicine Meetings |Gene ... - November 12th, 2018
- Stem Cell Regenerative Medicine Conferences 2018 Zurich ... - November 2nd, 2018
- Biologic Stem Cell Medicine and Therapy | RestorePDX - November 1st, 2018
- Stem Cell Therapy NYC, Regenerative Medicine Injections ... - July 11th, 2018
- Stem Cell Therapy San Antonio TX | Alternative ... - October 12th, 2017
- Human skin cells transformed directly into motor neurons - Washington University School of Medicine in St. Louis - September 8th, 2017
- Cambridge Enterprise and Qkine to drive stem cell and regenerative medicine research - Business Weekly - September 2nd, 2017
- FDA announces actions regarding stem cell treatments - Lexology (registration) - September 1st, 2017
- Six Japanese arrested over medical treatments using blood taken from umbilical cords, which are popular with Chinese ... - South China Morning Post - September 1st, 2017
- In utero stem cell transplants may replace riskier childhood transplants for multiple conditions - Medical Xpress - August 31st, 2017
- Human Stem Cells Fight Parkinson's Disease in Monkeys - Scientific American - August 31st, 2017
- Puppies benefit from stem cell treatment for children with spina bifida - University of California - August 31st, 2017
- Why Doug Baldwin went to England for stem-cell therapy - The News Tribune (blog) - August 29th, 2017
- FDA moves to curb dangerous stem cell clinics - Philly.com - August 29th, 2017
- Stem Cell Treatment Helps Puppies With Spina Bifida - Technology Networks - August 29th, 2017
- US FDA steps up scrutiny of stem cell therapies - Reuters - August 29th, 2017
- ICMR's stem cell research guidelines soon to be released - ETHealthworld.com - August 29th, 2017
- Stem cell treatment for children with spina bifida helps dogs first - Phys.Org - August 25th, 2017
- 'Beating Heart' Patch Offers New Hope for Desperately Ill Patients - NBCNews.com - August 25th, 2017
- Yeargan Uses Patients Own Cells To Heal - Greater Wilmington Business Journal - August 25th, 2017
- State's Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial - UC San Diego Health - August 25th, 2017
- Researcher Seeks to Unravel the Brain's Genetic Tapestry to Tackle Rare Disorder - University of Virginia - August 23rd, 2017
- Mouse Model of Human Immune System Inadequate for Stem Cell Studies - Technology Networks - August 23rd, 2017
- Mouse model of human immune system inadequate for stem cell ... - Medical Xpress - August 22nd, 2017
- Stem Cell Treatments for Lung Diseases Advance - Healthline - Healthline - August 22nd, 2017
- UTMB lung experiment flies into space - Austin American-Statesman - August 22nd, 2017
- These Six Startups From Y Combinator's Demo Day 1 Are Ready to Transform Our World - Futurism - August 22nd, 2017
- Novel stem cell-derived model created of inflammatory neurological disorder - Medical Xpress - August 10th, 2017
- Test results after stem cell transplant for multiple myeloma can ... - Medical Xpress - August 10th, 2017
- Are Stem Cell Companies Abusing ClinicalTrials.gov? - PLoS Blogs (blog) - August 10th, 2017
- Okyanos Center for Regenerative Medicine to Hold Stem Cell Symposium in Freeport - Benzinga - August 9th, 2017
- About Us - Stem Cell Medicine :: STEM CELL MEDICINE LTD. - August 4th, 2017
- Engineered Skin Cells Control Type 2 Diabetes in Mice: Study - Sioux City Journal - August 4th, 2017
- Qkine synchronises licensing deal - Global University Venturing - August 4th, 2017
- Honor for pioneering equine stem cell researcher - Horsetalk - August 3rd, 2017
- Speculator makes case for candidates to end years of hurt for stem cell investors - The Pharma Letter (registration) - July 31st, 2017
- Dozens of US clinics sell unproven stem cell therapies for heart failure - Reuters - July 30th, 2017
- The Big Deal About Stem Cell Therapies and Regenerative Medicine - PR Newswire UK (press release) - July 30th, 2017
- Regenexx Announces Successful Merger with Harbor View Medical - OrthoSpineNews - July 12th, 2017
- Stem Cells Guided by Electric Fields May Offer New Therapies for ... - Genetic Engineering & Biotechnology News (press release) - July 12th, 2017
- Danvers health group offers alternative solution to surgery - Wicked Local North of Boston - July 4th, 2017
- LMU-DCOM student selected for research project - The Middlesboro Daily News - July 1st, 2017
- Siberian scientists say stem cells can treat varicose veins - Russia Beyond the Headlines - June 30th, 2017
- Stemcell Stroke hold the key to changing the face of medicine forever. - Checkbiotech.org (press release) - June 30th, 2017
- A New Path for US Stem Cell Inc (OTCMKTS:USRM) - The Oracle Dispatch - June 28th, 2017
- UIC Launches Stem Cell, Regenerative Medicine Center - Chicago Tonight | WTTW - June 13th, 2017
- Stem Cell Research at Johns Hopkins Medicine: Spinal ... - May 29th, 2017
- INTERNATIONAL REGENERATIVE MEDICINE COMMUNITY TO ... - GlobeNewswire (press release) - May 13th, 2017
- Fighting arthritis: Researchers edit stem cells to fight inflammation - Kasmir Monitor - April 29th, 2017
- Streamlining Stem Cell Manufacturing - Genetic Engineering & Biotechnology News (press release) - April 24th, 2017
- Cord Blood Association Names STEM CELLS Translational ... - Benzinga - April 1st, 2017
- 3 women blinded in stem cell clinical trial - AOL - March 17th, 2017
- Stem Cell Therapies for Degenerative Disc Disease - Clinical Pain Advisor (registration) - March 17th, 2017
- UC Davis licenses novel compound that helps stem cells regenerate bone - HealthCanal.com (press release) (blog) - March 4th, 2017
- Study of SanBio's Stem Cell Treatment for Stroke Receives Innovation Award from American Heart Association - Yahoo Finance - February 27th, 2017
- World-Renowned Stem Cell Transplantation Expert joins Cellect's Advisory Board - P&T Community - February 27th, 2017
- Obesity reprograms muscle stem cells -- ScienceDaily - Science Daily - February 23rd, 2017
- Early-stage study validates Cellect Bio's method of stem cell selection; shares ahead 19% - Seeking Alpha - February 22nd, 2017
- Cancer stem cell - Wikipedia - February 4th, 2017
- Adult Stem Cell Medicine Technology | Asymmetrex - November 27th, 2016
- Duke Stem Cell and Regenerative Medicine Program - November 2nd, 2015
- Eli and Edythe Broad Center for Regenerative Medicine and ... - October 22nd, 2015
- California Stem Cell Report - October 17th, 2015
- Hair Restoration Treatment Uses Novel Stem Cell Therapy ... - October 12th, 2015
- CD47 - Research and Clinical Trials - Institute for Stem ... - September 25th, 2015
- Stem Cells News -- ScienceDaily - September 8th, 2015